Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
55.82
+0.14 (+0.25%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CVS Health Corp
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
U.S. Weekly Fundflows Insight Report: Equity ETFs, Conventional Funds Suffer Net Redemptions For The Fund-Flows Week
February 08, 2024
Investors were net sellers of fund assets (including those of conventional funds and ETFs) for the second week in three, redeeming a net $15.7 billion for the LSEG Lipper fund-flows week ended...
Via
Talk Markets
Topics
ETFs
What's Going On With Health Insurance Firm UnitedHealth Stock Today?
February 08, 2024
Explore UnitedHealth Group Inc stock insights! Discover recent market trends, CEO perspectives, and financial highlights.
Via
Benzinga
Critical Insights From CVS Health Analyst Ratings: What You Need To Know
February 08, 2024
Via
Benzinga
The 3 Most Undervalued Stocks With Strong Fundamentals to Buy in February 2024
February 07, 2024
If you are on the hunt for undervalued stocks, look no further than these three companies with strong fundamentals.
Via
InvestorPlace
CVS Health (CVS) Q4 2023 Earnings Call Transcript
February 07, 2024
CVS earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
CVS Beats Q4 Forecasts with $93.8B Revenue and $2.12 EPS
February 07, 2024
CVS Health Corp. reported a successful Q4 2023, achieving $93.8 billion in revenue.
Via
Talk Markets
Earnings Scheduled For February 7, 2024
February 07, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via
Benzinga
Earnings Preview: CVS Health
February 06, 2024
Via
Benzinga
What the Options Market Tells Us About CVS Health
February 05, 2024
Via
Benzinga
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
February 07, 2024
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CVS Health's Q4 Earnings Relieve Investor Concerns But Lowers 2024 Profit Guidance Citing Elevated Medical Cost Trends
February 07, 2024
CVS Health beats Q4 expectations with $2.12 adjusted EPS, allays concerns over healthcare costs. Sales rise 11.9% to $93.81 billion.
Via
Benzinga
Nasdaq, S&P 500 Futures Stall As Rate Worries Dampen Earnings Cheer: Why This Analyst Isn't Worried 'Too Much' About Short-Term Risks
February 07, 2024
The focus once again shifts to speeches by Federal Reserve officials, as traders seek clarity on the potential schedule for rate cuts.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
CVS Health Unusual Options Activity For February 02
February 02, 2024
Via
Benzinga
The 3 Most Undervalued S&P 500 Stocks to Buy in February 2024
February 06, 2024
With undervalued S&P 500 stocks, you get the best of both worlds: the confidence from large-cap companies and a credible bargain.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
The 7 Most Undervalued Large-Cap Stocks to Buy in February 2024
February 06, 2024
All eyes are on the 'Magnificent Seven," but these seven undervalued large-cap stocks may be worth considering instead.
Via
InvestorPlace
The 3 Most Undervalued Long-Term Stocks to Buy in February 2024
February 05, 2024
These undervalued stocks for February 2024 are priced for decline, yet they are thriving businesses participating in key growth trends.
Via
InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Check Out What Whales Are Doing With CVS
January 18, 2024
Via
Benzinga
Wall Street Favorites: 3 Undervalued Stocks With Strong Buy Ratings for January 2024
January 30, 2024
Although it may be tempting to ride the coattails of the usual suspects, investors should consider undervalued stocks January 2024.
Via
InvestorPlace
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.
Via
Benzinga
Did You Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts?
January 30, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Wall Street HATES These Three Stocks
January 29, 2024
Professional investors on Wall Street are betting against a handful of consumer stocks.
Via
Talk Markets
Fortune 100 Giant Tyson Foods Breaks Ties With CVS Caremark, Marks Shift Towards Transparent Pharmacy Benefit Managers
January 25, 2024
Tyson Foods shifts from CVS Caremark to startup Rightway, targeting a 15% reduction in pharmacy costs. Explore Tyson's move and its impact on the pharmacy benefits landscape.
Via
Benzinga
Humana Blames Medicare Advantage As Stock Falls After Larger Than Expected Quarterly Loss, Grim Outlook
January 25, 2024
Humana faces challenges as Q4 2023 earnings disappoint. Adjusted EPS loss at $(0.11), revenue at $25.73 billion.
Via
Benzinga
Humana Dives On Huge 2024 Earnings Warning
January 25, 2024
The health insurer says earnings will be barely half of estimates.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
January 23, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 22, 2024
Via
Benzinga
EXCLUSIVE: The 'Buy Everything' Market Is Over: Synopsys-Ansys Merger Provides Fertile Ground For This Stock Picker
January 18, 2024
The "buy everything" sentiment that powered equity indices higher last quarter is over. It's a stock picker's market, Marc Chaikin says.
Via
Benzinga
Medicare Patients Alert! Biden Administration Finalizes Rule to Streamline Health Insurance Prior Authorization
January 18, 2024
Biden Administration's rule for health information exchange and prior authorization processes in government-backed insurance plans. Streamlined procedures, reduced wait times, and estimated $15 billion...
Via
Benzinga
Humana Stock Falls Ill On This Warning; UNH, CVS Catch Virus
January 18, 2024
Humana slashed its Q4 earnings outlook on higher medical costs and warned about weak Medicare Advantage enrollment.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.